Results 161 to 170 of about 400,383 (291)
This study established clinical cohorts of respiratory viral infections and identified sphinganine‐phosphate (SA) as a metabolite significantly upregulated post‐infection through metabolomic analysis. In vitro and in vivo experiments demonstrated that SA promotes the generation of effector CD8+ T cells via the SOCS1/JAK1/STAT1 pathway, which ...
Zhongwen Hu +10 more
wiley +1 more source
Case Report: Herpes zoster-associated abdominal wall bulge with ipsilateral muscle atrophy. [PDF]
Wang Y, Chen J.
europepmc +1 more source
Infections after liver transplantation: An analysis of 101 consecutive cases [PDF]
Esquivel, C +8 more
core +1 more source
ABSTRACT Ritlecitinib is an oral JAK3/TEC family kinase inhibitor approved for individuals aged ≥ 12 years with severe alopecia areata. Here we report interim efficacy and safety results with ritlecitinib up to Month 24 in the Asian subpopulation from the ALLEGRO phase 2b/3 and ALLEGRO‐LT studies.
Rie Ueki +13 more
wiley +1 more source
Postsurgical skin ulcers caused by cytomegalovirus vasculopathy in a renal transplant recipient
Shikha Rao, MD, Justin Cheeley, MD
doaj +1 more source
Prevalence of herpes zoster in individuals who have received COVID-19 vaccine and/or had COVID-19: a cross-sectional study. [PDF]
Ispir NG +4 more
europepmc +1 more source
ABSTRACT Objective To quantify the transplacental transfer of aciclovir at an amount equivalent to 2 g of valaciclovir corresponding to the fractionated dosing regimen given four times daily used to reduce congenital cytomegalovirus (CMV) transmission and to treat the CMV‐infected fetus. Design Experimental ex vivo study.
Helyett Ollivier +9 more
wiley +1 more source
Infectious retinitis associated with JAK inhibitors: the ongoing duality of JAK inhibitors. [PDF]
Pulido JS, Mano F, Casella M, Ishida S.
europepmc +1 more source

